HighTower Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,400
Closed -$2K 2334
2018
Q4
$2K Hold
12,400
﹤0.01% 2170
2018
Q3
$2K Sell
12,400
-9,100
-42% -$177K ﹤0.01% 2245
2018
Q2
$6K Buy
21,500
+10,200
+90% +$211K ﹤0.01% 2166
2018
Q1
$6K Sell
11,300
-200
-2% -$5.53K ﹤0.01% 2111
2017
Q4
$15K Buy
11,500
+400
+4% +$10.6K ﹤0.01% 2169
2017
Q3
$10K Sell
11,100
-500
-4% -$13.3K ﹤0.01% 2149
2017
Q2
$16K Buy
+11,600
New +$245K ﹤0.01% 2086

Other funds holding EXEL

HighTower Advisors's EXEL Position: Q1 2026 in Review

HighTower Advisors increased its Exelixis (EXEL) stake by 223% in Q1 2026, buying an estimated $4.65M and bringing the position to 156,765 shares worth $6.72M. The position accounts for 0.01% of the portfolio, ranked #1056.

HighTower Advisors first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • HighTower Advisors held 156,765 shares of Exelixis worth $6.72M as of Q1 2026.
  • HighTower Advisors bought 108,261 Exelixis shares in Q1 2026, an estimated $4.65M.
  • Exelixis made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1056 holding.
  • HighTower Advisors first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.